Covid: Pfizer’s Omicron vaccine to be ready in March

Published by Manon C. · Published on 12 January 2022 at 15h23
This Monday January 10, 2022, Pfizer announced their new version of the vaccine targeting the Omicron variant will be ready in March.

Here is some news likely to convince the last vaccine refractories alluding to the fact the current vaccines do not protect enough against Omicron. This Monday January 10, 2022, Pfizer CEO announced their version of the Omicron vaccine could be ready in March, as he already said at the end of November.

I don’t know if we will need it. I don’t know if and how it will be used. But we’ll be ready and in fact, we already starting manufacturing some of these quantities at risk […]. And the hope is that we will achieve something that will have way, way better protection, particularly against infections because the protection against the hospitalizations and the severe disease, it is, it is reasonable right now, with the current vaccines as long as you are having let’s say the third dose”, the company’s CEO, Albert Bourla, told CNBC, also announcing studies will be carried out to find out if a fourth dose of the vaccine will be needed.

As for Moderna CEO Stéphane Bancel, he said the pharmaceutical laboratory was working on a version of their vaccine aiming at Omicron. “Soon” entering the clinical trial phase, this version of the Moderna vaccine is to be ready by Fall.

We are discussing with public health leaders around the world to decide what we think is the best strategy for the potential booster for the fall of 2022. We believe it will contain omicron”, Bancel explained.

Practical information